pharmaphorum.com/news/uk-sc...
I currently take adulumimab for RA. I am told to shield because along with Methotrexate 10mg weekly. I am immuno-suppressed. Yet this article suggests that adulumimab is being used to treat elderly Covid sufferers in UK care homes. If I am taking a medication that is proving to have a beneficial anti inflammatory response, is my immunodeficiency less of risk than previously thought? I have never had the flu, or, serious cold while I have been taking this medication for over six years now. I have halved the methotrexate dose and got rid of hydroxychloroquine use several years ago. Recently, I have been in France and have stopped taking all prescription meds for almost three months now. I intend to resume when I am back in the future.
However, this article (and others similar to it) have really muddied the waters concerning adulumimab/ anti TNF therapies, Covid 19 and (un)necessary shielding.
Any answers?